Cognitive Enhancement Stack: Semax + Selank + NAD+ Research

# Cognitive Enhancement Stack: Semax + Selank + NAD+ Research

For Research Purposes Only — Not Intended for Human or Animal Consumption

Introduction

Semax, Selank, and NAD+ target different aspects of neurological function through distinct mechanisms. Semax primarily acts through BDNF upregulation and melanocortin receptor activation; Selank through GABAergic modulation and BDNF upregulation; and NAD+ through mitochondrial support and sirtuin activation in neurons. Together, they address cognitive function from complementary angles.

Semax: BDNF Upregulation and Cognitive Enhancement

As reviewed in the Semax article, the primary mechanism of cognitive enhancement is BDNF upregulation in the hippocampus and frontal cortex. BDNF promotes: - Synaptic plasticity (long-term potentiation) - Hippocampal neurogenesis - Neuronal survival - Dendritic arborization

Semax also activates melanocortin receptors (particularly MC4R), which independently modulate learning and memory through cAMP/PKA signaling in hippocampal neurons.

Primary cognitive targets: Working memory, attention, processing speed, neuroprotection

Selank: Anxiolytic Effects and Cognitive Clarity

Selank's primary mechanism — GABAergic modulation — has indirect but significant effects on cognitive function. Anxiety and stress impair cognitive performance through multiple mechanisms: - Elevated cortisol impairs hippocampal function and memory consolidation - Excessive amygdala activation competes with prefrontal cortex for attentional resources - Disrupted sleep (from anxiety) impairs memory consolidation

By reducing anxiety through GABAergic modulation, Selank may improve cognitive performance indirectly — a mechanism distinct from Semax's direct BDNF-mediated cognitive enhancement.

Selank also independently upregulates BDNF, providing a direct cognitive enhancement mechanism that complements Semax's effects. The combination of two BDNF-upregulating compounds may produce additive effects on hippocampal BDNF levels, though this has not been directly tested.

Primary cognitive targets: Anxiety-related cognitive impairment, stress resilience, mood-cognition interface

NAD+ and Neuronal Energetics

Neurons are among the most metabolically demanding cells in the body, consuming approximately 20% of the body's energy despite comprising only 2% of body mass. This high energy demand makes neurons particularly vulnerable to mitochondrial dysfunction and NAD+ depletion.

Age-related NAD+ decline in the brain has been proposed to contribute to: - Reduced synaptic energy availability - Impaired DNA repair in post-mitotic neurons - Reduced sirtuin activity (particularly SIRT1 and SIRT3, which regulate neuronal metabolism) - Increased neuroinflammation (through reduced SIRT1-mediated NF-κB inhibition)

NAD+ precursor supplementation has been shown to increase brain NAD+ levels in animal models. Stein and Imai (2014) demonstrated that NMN supplementation restored NAD+ levels in the aging mouse brain and improved cognitive performance in aged animals.

Primary cognitive targets: Neuronal energy metabolism, neuroprotection, neuroinflammation reduction

Mechanistic Complementarity

The three compounds target different aspects of cognitive function: - Semax: Direct BDNF upregulation → synaptic plasticity, neurogenesis - Selank: Anxiety reduction + BDNF upregulation → stress resilience, indirect cognitive enhancement - NAD+: Neuronal energetics + sirtuin activation → metabolic support, neuroprotection

The combination addresses both the "software" of cognition (synaptic plasticity, neurotransmitter balance) and the "hardware" (neuronal energy supply, mitochondrial function) — a complementarity that is mechanistically rational.

Limitations

All three compounds have been studied primarily in animal models or in Russian clinical trials with limited independent replication. The combination has not been studied in a single research model. The cognitive enhancement effects of NAD+ in humans are less well-established than those of Semax and Selank in animal models.

References

1. Dolotov, O.V., et al. (2006). Semax regulates BDNF and trkB expression in the rat hippocampus. Brain Research, 1117(1), 54–60.
2. Semenova, T.P., et al. (2010). Selank modulates GABA-A receptor expression. Doklady Biochemistry and Biophysics, 432(1), 127–129.
3. Stein, L.R., & Imai, S. (2014). Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging. EMBO Journal, 33(12), 1321–1340.